Theyre both powerful medications, and you and your provider will choose the one that fits your health goals, budget, and how your body responds
Conditions such as insulin resistance, elevated A1C levels, fatty liver disease, hypertension, and central obesity can make anesthesia and surgery more technically complex
They have been very responsive to my request
After propensity score matching against multiple antidiabetic drug classes (insulin, metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas), results showed: No significant increase in thyroid cancer incidence Median follow-up of ~4.5 years Risk estimates comparable or lower than other glucose-lowering therapies Overall, current epidemiological evidence does not support a clinically meaningful increase in thyroid cancer risk in humans
Another glutaminase inhibitor, JHU-083, extensively inhibits Gln-metabolizing enzymes and increases the concentrations of Gln and glucose in the TME by inhibiting glycolysis, relieving the hypoxic state
A year after stopping, the picture was mixed, but not uniformly negative